ClinicalTrials.gg
RecruitingNCT06670066Updated Mar 19, 2026

Rigorous Evaluation of Let's Talk Birth Control

An interventional study of Let's Talk Birth Control in Sexual Behavior and Adolescent Behavior, sponsored by Child Trends. Recruiting at 2 sites in United States. Open to female participants aged 15 Years to 24 Years. Per ClinicalTrials.gov, last updated 2026-03-19.

Sponsored by Child Trends · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
1,500
Allocation
Randomized
Ages
15 Years to 24 Years
Sex
Female
01

Study summary

The goal of this cluster-level randomized controlled trial is to evaluate the impacts of Let's Talk Birth Control, a clinical decision support intervention for adolescents that consists of a printed contraceptive decision aid (CDA), contraceptive counseling, and a QR code to the Bedsider.org Method Explorer (ME). The goal of Let's Talk Birth Control is to reduce rates of sex without a contraceptive method among adolescent patients, increase use of preferred contraceptive method, as well as to increase self-efficacy to discuss, obtain, and correctly use contraceptive methods

The primary research questions are:

  • Does receiving care from a health center participating in Let's Talk Birth Control reduce rates of sex without a contraceptive method among adolescent patients compared to those visiting a standard of care control health center?
  • Does receiving care from a health center participating in Let's Talk Birth Control increase use of preferred contraceptive method among adolescent patients compared to those visiting a standard of care control health center?

The evaluation will focus on the impacts of receiving the Let's Talk Birth Control intervention, as compared to receiving standard health care services.

As part of this study:

  • All participants will be asked to complete baseline, 1-week post-intervention, and 9-month follow-up surveys.
  • Participants at health centers randomized to receive the Let's Talk intervention, will be asked to:
  • Review the Let's Talk CDA independently prior to meeting with their healthcare provider
  • Participate in an observation focused on the provider's use of the CDA for contraceptive counseling during the healthcare visit (select participants only)
  • Participate in a focus group discussing their perceptions of the Let's Talk Birth Control intervention (select participants only)

Staff at health centers randomized to receive the Let's Talk intervention will be asked to:

  • Complete a 45-60 minute online asynchronous training covering patient-centered contraceptive counseling (PCCC) for adolescents and using the CDA
  • Use the Let's Talk CDA to facilitate patient-centered contraceptive counseling with patients that have enrolled in the study
02

Conditions studied

  • Sexual Behavior
  • Adolescent Behavior
03

In context

Sexual Behavior

224 studies on the registry are indexed under Sexual Behavior; 30 are open to participants now.

This study's planned enrollment of 1,500 is above the median of 264 across 179 interventional studies indexed under Sexual Behavior.

Browse Sexual Behavior studies →

Lead sponsor

Child Trends is the lead sponsor of 11 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 24 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Health Centers:

  • Serve 400+ patients assigned female at birth (AFAB) aged 15-24 receiving sexual and reproductive health (SRH) services or general wellness exams annually. Although the project team may enroll rural health centers with smaller populations
  • Have not implemented an adolescent SRH patient-centered training recently
  • Do not utilize a decision aid (CDA) designed for adolescent patients

Participants:

  • Assigned female at birth
  • Seeking sexual and reproductive services or general wellness exams at an enrolled community health center
  • Have had penile-vaginal sex in the past year or are interested in discussing birth control with their provider
  • Agree to be in study

Exclusion criteria

Exclusion Criteria:

Health Centers

  • Does not serve at least 400 AFAB aged 15-24 receiving SRH services or general wellness exams annually
  • Has recently implemented an adolescent SRH training
  • Currently using a CDA designed for adolescent patients

Participants:

  • Does not agree to be in study
  • Is pregnant or is trying to become pregnant
  • Does not have access to a phone to receive text messages
  • Does not speak English or Spanish
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,500 participants (estimated)

Study arms

  • Experimental
    Adolescents receiving Let's Talk Birth Control

    Participants in the Let's Talk Birth Control condition receive access to the CDA materials, contraceptive counseling with trained healthcare providers, and asynchronous access to the Bedsider ME web platform.

    Behavioral: Let's Talk Birth Control

  • No intervention
    Adolescents receiving standard reproductive and sexual health care services

    Participants in the control condition receive standard health care services from their medical provider. Health centers in the control condition will not be using an adolescent-focused sexual and reproductive health CDA or contraceptive counseling initiative.

Interventions

  • BehavioralLet's Talk Birth Control

    Let's Talk is an innovative, multi-level intervention addressing adolescents and providers that includes both in-person and online components and is feasible to implement in clinical settings. The three core components are: (1) a printed contraceptive decision aid (CDA) with a QR code linking to the Method Explorer (ME) page on Power to Decide's online birth control website, Bedsider; (2) the Bedsider ME, with information on the full range of contraceptive methods and a personalized method comparison feature; and (3) an online training for providers on Patient-centered Contraceptive Counseling (PCCC), including use of the CDA to support shared decision-making with adolescents.

06

What researchers measure

Primary outcomes

  1. Rates of sex without a contraceptive method

    Penile-vaginal sex without any contraception (including condom) in the past 3 months (yes/no). Yes if had sex in the past 3 months and did not use a contraceptive method "all the time". No if did not have sex or used a contraceptive method "all the time".

    Time frame: 9 months post-intervention

  2. Use of preferred contraceptive method

    Currently using preferred birth control method (yes/no). Respondents are coded as No if they report there is a method of birth control that they would like to be using right now but are not currently using. Otherwise, they are coded as Yes.

    Time frame: 9 months post-intervention

Secondary outcomes

  1. Self-efficacy to discuss contraception with a provider

    Confident they can talk about birth control with their doctor or health care provider (yes/no, "Strongly agree" vs other responses).

    Time frame: 1 week post-intervention

  2. Self-efficacy to make informed decisions about contraception

    Strongly agree that they 1) feel sure about the best birth control option for their needs and 2) have received enough support and advice to make a choice about birth control methods (yes/no, "Strongly agree" to both items vs other responses)

    Time frame: 1 week post-intervention

  3. Intentions to use contraception

    Intends to use contraception if chooses to have penile-vaginal sex in the next 3 months (yes/no, "Yes, definitely" vs other responses)

    Time frame: 1 week post-intervention

  4. Self-efficacy to use contraception

    4-item Likert scale capturing 1) confidence in starting a new method of birth control if they want, 2) using birth control correctly, 3) knowing the steps needed to continue a birth control method, and 4) avoiding unintended pregnancy (1-5 scale)

    Time frame: 1 week post-intervention

  5. Knowledge of contraceptive methods

    Knowledge of contraceptive methods (% correct out of 6 items)

    Time frame: 1 week after post-intervention

  6. Attitudes about contraception

    6-item Contraceptive Concerns and Beliefs Scale

    Time frame: 1 week post-intervention

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06670066
Lead sponsor
Child Trends
Collaborators
University of California, San Francisco, Power to Decide
Responsible party
Sponsor
First posted
Nov 1, 2024
Start date
Jan 15, 2025
Primary completion
Aug 31, 2027 (estimated)
Completion
Aug 31, 2027 (estimated)
Last update
Mar 19, 2026

Study contacts

Kate Welti, MPP
Contact
kwelti@childtrends.org
202-744-2413
Riley Steiner, Mph, PhD
Contact
rsteiner@powertodecide.org
202-478-8515

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion